Generate Biomedicines, Inc.
No trades
No trades
Compare with Generate Biomedicines, Inc.
−203.15 M USD
31.89 M USD
55.05 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Profile
Sector
Industry
CEO
Michael T. Nally
Website
Headquarters
Somerville
Founded
2018
IPO date
Feb 27, 2026
IPO offer price
16.00 USD
ISIN
US3709201004
CUSIP
370920100
FIGI
BBG00X9D0NZ0
Identifiers
ISIN US3709201004
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Weight1.05%
Market value16.91 M
Weight0.01%
Market value2.12 M
Weight0.91%
Market value1.89 M
Weight0.01%
Market value572.15 K
Weight0.70%
Market value358.39 K
Weight0.02%
Market value305.72 K
Weight0.76%
Market value12.62 K
Weight0.02%
Market value874.24
Explore more ETFs
Frequently asked questions
The current price of GENB is 13.58 USD — it has increased by 0.15% in the past 24 hours. Watch Generate Biomedicines, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Generate Biomedicines, Inc. stocks are traded under the ticker GENB.
GENB stock has fallen by −3.14% compared to the previous week, the month change is a −3.82% fall, over the last year Generate Biomedicines, Inc. has showed a 13.07% increase.
We've gathered analysts' opinions on Generate Biomedicines, Inc. future price: according to them, GENB price has a max estimate of 30.00 USD and a min estimate of 22.00 USD. Watch GENB chart and read a more detailed Generate Biomedicines, Inc. stock forecast: see what analysts think of Generate Biomedicines, Inc. and suggest that you do with its stocks.
GENB reached its all-time high on Jun 30, 2026 with the price of 18.18 USD, and its all-time low was 11.00 USD and was reached on Mar 4, 2026. View more price dynamics on GENB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GENB stock is 4.50% volatile and has beta coefficient of 0.39. Track Generate Biomedicines, Inc. stock price on the chart and check out the list of the most volatile stocks — is Generate Biomedicines, Inc. there?
Today Generate Biomedicines, Inc. has the market capitalization of 1.75 B, it has decreased by −5.04% over the last week.
Yes, you can track Generate Biomedicines, Inc. financials in yearly and quarterly reports right on TradingView.
Generate Biomedicines, Inc. is going to release the next earnings report on Sep 2, 2026. Keep track of upcoming events with our Earnings Calendar.
GENB earnings for the last quarter are −1.07 USD per share, whereas the estimation was −0.51 USD resulting in a −110.63% surprise. The estimated earnings for the next quarter are −0.51 USD per share. See more details about Generate Biomedicines, Inc. earnings.
Generate Biomedicines, Inc. revenue for the last quarter amounts to 7.22 M USD, despite the estimated figure of 5.28 M USD. In the next quarter, revenue is expected to reach 5.30 M USD.
GENB net income for the last quarter is −61.45 M USD, while the quarter before that showed −41.69 M USD of net income which accounts for 0.00% change. Track more Generate Biomedicines, Inc. financial stats to get the full picture.
No, GENB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 21, 2026, the company has 312 employees. See our rating of the largest employees — is Generate Biomedicines, Inc. on this list?
Like other stocks, GENB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Generate Biomedicines, Inc. stock right from TradingView charts — choose your broker and connect to your account.